Environmental factors and primary prevention in type 1 diabetes

Pediatric Endocrinology, Diabetes and Metabolism

Volumn 15, Issue 4, 2009, Pages 227-232

  Ilonen, Jorma ^a,b   Vaarala, Outi ^c   Åkerblom, Hans K ^d   Knip, Mikael ^d,e  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Infant nutrition; Primary prevention trial; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; CELL ADHESION MOLECULE; COD LIVER OIL; CROSS REACTING ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DOCOSAHEXAENOIC ACID; FOOD ALLERGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INSULIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; OMEGA 3 FATTY ACID; PROBIOTIC AGENT;

ALLERGY; ANTIGEN PRESENTATION; ANTIGENICITY; ARTICLE; ARTIFICIAL MILK; ATOPY; AUTOIMMUNITY; BREAST FEEDING; CD8+ T LYMPHOCYTE; CELL DESTRUCTION; CYTOTOXIC T LYMPHOCYTE; DIET SUPPLEMENTATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GROUPS BY AGE; HAPLOTYPE; HELPER CELL; HEREDITY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INCIDENCE; INFANCY; INFANT; INFECTION; INFLAMMATION; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; LYMPHOCYTIC INFILTRATION; NUTRITION; PANCREAS ISLET BETA CELL; PATHOGENESIS; PREGNANCY; PRIMARY PREVENTION; REGULATORY T LYMPHOCYTE; RISK FACTOR; THYMUS;

EID: 84904848521     PISSN: 1234625X     EISSN: 20838441     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Patterson C.C., Dahlquist G.G., Gyurus E. et al.: Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet, 2009, 373, 2027-2033.
2. Tuomilehto J., Karvonen M., Pitkaniemi J. et al.: Record-high incidence of type I (insulin-dependent) diabetes mellitus in Finnish children. The Finnish Childhood Type I Diabetes Registry Group. Diabetologia, 1999, 42, 655-660.
3. Harjutsalo V., Sjoberg L., Tuomilehto J.: Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet, 2008, 371, 1777-1782.
4. Daneman D.: Type 1 diabetes. Lancet, 2006, 367, 847-858.
5. Imagawa A., Hanafusa T., Uchigata Y. et al.: Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care, 2003, 26, 2345-2352.
6. Hummel M., Bonifacio E., Schmid S. et al.: Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in off spring of diabetic parents. Ann. Intern. Med., 2004, 140, 882-886.
7. Vaarala O., Atkinson M.A., Neu J.: The "perfect storm" for type 1 diabetes. The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes, 2008, 57, 2555-2562.
8. Kvity S., Agmon-Levin N., Blank M. et al.: Infections and autoimmunity - friends or foes. Trends Immunol., 2009, in press.
9. Riedler J., Braun-Fahrlander C., Eder W. et al.: Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet, 2001, 358, 1129-1133.
10. Savilahti E., Kuitunen M., Vaarala O.: Pre and probiotics in the prevention and treatment of food allergy. Curr. Opin. Allergy Clin. Immunol., 2008, 8, 243-248.
11. Borch-Johnsen K., Joner G., Mandrup-Poulsen T. et al.: Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis. Lancet, 1984, 2, 1083-1086.
12. Gerstein H.C.: Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literature. Diabetes Care, 1994, 17, 13-19.
13. Norris J.M., Scott F.W.: A meta-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role? Epidemiology, 1996, 7, 87-92.
14. Sarugeri E., Dozio N., Meschi F. et al.: Cellular and humoral immunity against cow's milk proteins in type 1 diabetes. J. Autoimmunol., 1999, 13, 365-373.
15. Savilahti E., Saukkonen T.T., Virtala E.T. et al.: Increased levels of cow's milk and beta-lactoglobulin antibodies in young children with newly diagnosed IDDM. The Childhood Diabetes in Finland Study Group. Diabetes Care, 1993, 16, 984-989.
16. Luopajarvi K., Savilahti E., Virtanen S.M. et al.: Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood. Pediatr. Diabetes, 2008, 9, 434-441.
17. Mojibian M., Chakir H., Lefebvre D.E. et al.: Diabetes-specifi c HLA-DR-restricted proinfl ammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes, 2009, 58, 1789-1796.
18. MacFarlane A.J., Burghardt K.M., Kelly J. et al.: A type 1 diabetes-related protein from wheat (Triticum aestivum). cDNA clone of a wheat storage globulin, Glb1, linked to islet damage. J. Biol. Chem., 2003, 278, 54-63.
19. Klemetti P., Savilahti E., Ilonen J. et al.: T-cell reactivity to wheat gluten in patients with insulin-dependent diabetes mellitus. Scand. J. Immunol., 1998, 47, 48-53.
20. Vaarala O., Paronen J., Otonkoski T. et al.: Cow milk feeding induces antibodies to insulin in children - a link between cow milk and insulin-dependent diabetes mellitus? Scand. J. Immunol., 1998, 47, 131-135.
21. Martin J.M., Trink B., Daneman D. et al.: Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM). Ann. Med, 1991, 23, 447-452.
22. Vaarala O., Knip M., Paronen J. et al.: Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes, 1999, 48, 1389-1394.
23. Paronen J., Vaarala O., Savilahti E. et al.: Soluble adhesion molecules and oral antigen feeding in infants. Pediatr. Res., 1996, 40, 276-279.
24. Karges W., Hammond-McKibben D., Cheung R.K. et al.: Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial. Diabetes, 1997, 46, 557-564.
25. Mäkelä M., Vaarala O., Hermann R. et al.: Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin. J. Autoimmun., 2006, 27, 54-61.
26. Sabbah E., Savola K., Ebeling T. et al.: Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care, 2000, 23, 1326-1332.
27. Vandewalle C.L., Falorni A., Lernmark A. et al.: Associations of GAD65- and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry. Diabetes Care, 1997, 20, 1547-1552.
28. Graham J., Hagopian W.A., Kockum I. et al.: Genetic eff ects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes, 2002, 51, 1346-1355.
29. Kupila A., Keskinen P., Simell T. et al.: Genetic risk determines the emergence of diabetesassociated autoantibodies in young children. Diabetes, 2002, 51, 646-651.
30. Alizadeh B.Z., Koeleman B.P.: Genetic polymorphisms in susceptibility to type 1 diabetes. Clin. Chim. Acta, 2008, 387, 9-17.
31. Barrett J.C., Clayton D.G., Concannon P. et al.: Genome-wide association study and metaanalysis fi nd that over 40 loci aff ect risk of type 1 diabetes. Nat. Genet., 2009 [ahead of print].
32. Wucherpfennig K.W.: T cell receptor crossreactivity as a general property of T cell recognition. Mol. Immunol., 2004, 40, 1009-1017.
33. Mathis D., Benoist C.: Aire. Ann. Rev. Immunol., 2009, 27, 287-312.
34. Pugliese A.: Central and peripheral autoantigen presentation in immune tolerance. Immunology, 2004, 111, 138-146.
35. Sabbah E., Savola K., Kulmala P. et al.: Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group. Clin. Exp. Immunol., 1999, 116, 78-83.
36. Walter M., Albert E., Conrad M. et al.: IDDM2/insulin VNTR modifi es risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia, 2003, 46, 712-720.
37. Hermann R., Laine A.P., Veijola R. et al.: The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity. Diabetologia, 2005, 48, 1766-1775.
38. Lempainen J., Vaarala O., Mäkelä M. et al.: Interplay between PTPN22 C1858T polymorphism and cow's milk formula exposure in type 1 diabetes. J. Autoimmunol., 2009, 33, 155-164.
39. Pérez-Bravo F., Carrasco E., Gutierrez-Lopez M.D. et al.: Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children. J. Mol. Med., 1996, 74, 105-109.
40. Kostraba J.N., Cruickshanks K.J., Lawlerheavner J. et al.: Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes, 1993, 42, 288-295.
41. Virtanen S.M., Kenward M.G., Erkkola M. et al.: Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia, 2006, 49, 1512-1521.
42. Stene L.C., Joner G.: Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am. J. Clin. Nutr., 2003, 78, 1128-1134.
43. Dahlquist G.G., Forsberg J., Hagenfeldt L. et al.: Increased prevalence of enteroviral RNA in blood spots from newborn children who later developed type 1 diabetes: a population-based case-control study. Diabetes Care, 2004, 27, 285-286.
44. Svensson J., Lindberg B., Jonsson B. et al.: Intrauterine exposure to maternal enterovirus infection as a risk factor for development of autoimmune thyroiditis during childhood and adolescence. Thyroid, 2004, 14, 367-370.
45. Chase H.P., Lescheck E., Rafkin-Mervis L. et al.: Nutritional intervention to prevent type 1 diabetes a pilot trial. ICAN: Infant, Child, & Adolescent Nutrition, 2009, 1, 98-107.
46. TRIGR Study Group: Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). Pediatr. Diabetes, 2007, 8, 117-137.
47. Åkerblom H.K., Knip M., Becker D. et al.: The TRIGR trial: testing the potential link between weaning diet and type 1 diabetes. Immun. Endoc. & Metab. Agents in Med. Chem., 2007, 7, 251-263.
48. Åkerblom H.K., Virtanen S.M., Ilonen J. et al.: Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia, 2005, 48, 829-837.
49. Schmid S., Buuck D., Knopff A. et al.: BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with type 1 diabetes by delaying exposure to gluten. Diabetologia, 2004, 47, 1130-1131.
50. Norris J.M., Yin X., Lamb M.M. et al.: Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA, 2007, 298, 1420-1428.
51. Lorini R., Minicucci L., Napoli F. et al.: Screening for type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention (Prevefi n Italy) - preliminary data. Acta Biomed., 2005, 76, suppl. 3, 31-35.
52. Ljungberg M., Korpela R., Ilonen J. et al.: Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes - the PRODIA study. Ann. N. Y. Acad. Sci., 2006, 1079, 360-364.